Behavior chemotherapy

Patent 6333357 Issued on December 25, 2001. Estimated Expiration Date:

November 5, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Patent References

Means and method for aiding individuals to stop smoking
Patent #: 4255439
Issued on: 03/10/1981
Inventor: Cooper

Compositions for treating tobacco withdrawal symptoms and methods for their use Patent #: 4999382
Issued on: 03/12/1991
Inventor: Wurtman, et al.

Inventor

Eig, Mark H.

Assignee

Be Able, LLC

Application

No. 434286 filed on 11/05/1999

US Classes:

514/646, Benzene ring containing514/319, The additional ring is one of the cyclos in a polycyclo ring system514/456, Bicyclo ring system having the hetero ring as one of the cyclos (e.g., chromones, etc.)514/654, The chain consists of two or more carbons which are unsubtituted or have acyclic hydrocarbyl substituents only514/810, ADDICTION514/811, Alcohol514/812Narcotic

Examiners

Primary: Criares, Theodore J.
Assistant: Kim, Jennifer

Attorney, Agent or Firm

Morrison & Foerster LLP

Foreign Patent References

2248392A GB. 08/13/1992

International Classes

A61K 031/135
A61K 031/445
A61K 031/35

Abstract

A protocol for permanent modification of behavior and elimination of undesired habits is described. The protocol involves stimulating the implicit memory, followed by continuing such stimulation in conjunction with psychological treatments followed by continuing said stimulation of the implicit memory and, in addition, stimulating the explicit memory. Use of this protocol results in a permanent replacement of undesirable behaviors with desirable ones.

Other References

Wu, Risheng "Clonidine sticking sheet and nicotine sticking sheet compound smoking stopping method" Faming Zhuanli Shenqing Gongkai Shuomingshu, 1998: 243491 5pp.
Sellers et al. "Do serotonin uptake inhibitors decrease smoking? Observations in a group of heavy drinkers." Journal of Clinical Psychopharmacology, ISSN: 0271-0749, (1987 Dec.) 7 (6) 417-420.
Hoffman et al., "Catecholamines, Sympathomimetic Drugs, and Adrenergic Receptor Antagonists," Goodman & Gilman's The Pharmacological Basis of Therapeutics (Ninth Ed., McGraw Hill) Chapter 10:199-242
Noble et al., "Citalopram A Review of its Pharmacology, Clinical Efficacy and Tolerability in the Treatment of Depression," CNS Drugs (1997) 8(5):410-431
Physicians' Desk Reference (52 Edition, Medical Economics Co. 1998) 974-975, 2161-2164, 2420-2422, 3209
Physicians Genrx (Mosby-Year Book, Inc., St. Louis, Mo. 1996) 1675-1677, 859-860
Rogers et al., "Long-term Efficacy and Safety of Donepezil in the Treatment of Alzheimer's Disease: An Interim Analysis of the Results of a US Multicentre Open Label Extension Study," European Neuropsychopharmacology (1998) 8:67-75
Rogers et al., "The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial," Dementia (1996) 7:293-303
Scates et al., "Focus on Citalopram: A Selective Serotonin Reuptake Inhibitor for the Treatment of Depression," Formulary (1998) 33:725-74